Roche scientists have developed a new neural organoid system that provides a human-relevant way to test the safety and efficacy of medicines that may affect the protective insulating layer surrounding neurons. This new approach gives us a closer, more biologically accurate way to study neurological diseases and to explore potential treatments long before they reach clinical trials. The work has now been published in Science Translational Medicine, marking an exciting step forward for neuroscience research. Read the full story here 👉 https://spkl.io/6042A5Guw A heartfelt thank you to the teams whose curiosity, persistence, and collaboration made this breakthrough possible. Your work is helping shape the future of brain health 👏. #RocheInnovation #pRED #Organoids #Neuroscience
Info
Roche ist ein globales Unternehmen mit Vorreiterrolle in der Erforschung und Entwicklung von Medikamenten und Diagnostika und ist darauf fokussiert, Menschen durch wissenschaftlichen Fortschritt ein besseres, längeres Leben zu ermöglichen. Dank der Kombination von Pharma und Diagnostika unter einem Dach ist Roche führend in der personalisierten Medizin - einer Strategie mit dem Ziel, jeder Patientin und jedem Patienten die bestmögliche Behandlung zukommen zu lassen. Roche ist das grösste Biotech-Unternehmen weltweit mit differenzierten Medikamenten für die Onkologie, Immunologie, Infektionskrankheiten, Augenheilkunde und Erkrankungen des Zentralnervensystems. Roche ist auch der bedeutendste Anbieter von In-vitro-Diagnostika und gewebebasierten Krebstests und ein Pionier im Diabetesmanagement. Seit der Gründung im Jahr 1896 erforscht Roche bessere Wege, um Krankheiten zu verhindern, zu erkennen und zu behandeln und leistet einen nachhaltigen Beitrag zur gesellschaftlichen Entwicklung. Zum Ziel des Unternehmens gehört es durch Kooperationen mit allen relevanten Partnern den Zugang von Patienten zu medizinischen Innovationen zu verbessern. Auf der Liste der unentbehrlichen Arzneimittel der Weltgesundheitsorganisation stehen heute 30 von Roche entwickelte Medikamente, darunter lebensrettende Antibiotika, Malariamittel und Krebsmedikamente. Ausgezeichnet wurde Roche zudem bereits das neunte Jahr in Folge als das nachhaltigste Unternehmen innerhalb der Pharma-, Biotechnologie- und Life-Sciences-Branche im Dow Jones Sustainability Index. Die Roche-Gruppe mit Hauptsitz in Basel, Schweiz ist in über 100 Ländern tätig und beschäftigte 2017 weltweit rund 94 000 Mitarbeiterinnen und Mitarbeiter. Im Jahr 2017 investierte Roche CHF 10,4 Milliarden in Forschung und Entwicklung und erzielte einen Umsatz von CHF 53,3 Milliarden. Genentech in den USA gehört vollständig zur Roche-Gruppe. Roche ist Mehrheitsaktionär von Chugai Pharmaceutical, Japan. Weitere Informationen finden Sie unter www.roche.com/careers #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalizedHealthcare #GreatPlaceToWork #Innovation
- Website
-
http://www.roche.com/
Externer Link zu Roche
- Branche
- Biotechnologieforschung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Switzerland 🇨🇭
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Spezialgebiete
- biotechnology, innovation, personalized healthcare, great place to work, diagnostics, pharmaceuticals, research, healthcare, personalised healthcare, diabetes care, genomics, healthcare technology, big data und Science
Orte
Beschäftigte von Roche
Updates
-
Type 1 diabetes remains a serious chronic condition, impacting millions of children and young people worldwide. For 15 years, Roche has been dedicated to improving global access through our #ChangingDiabetesInChildren partnership. We're proud to work alongside Novo Nordisk, International Society for Pediatric and Adolescent Diabetes (ISPAD), and the World Diabetes Foundation, having already improved care for over 64,000 children and trained 28,000+ healthcare professionals in 30 countries. Our future vision involves integrating evidence-based insights, digital innovation, and local ownership to ensure sustainable diabetes care within national health systems. Discover our journey and impact: https://lnkd.in/dFnR7yAg #DiabetesCare #HealthEquity #diabetesinchildren
-
How far would you go to achieve a dream? For Maturin Tchoumi, the journey has spanned 35 years and five continents, a lifelong pursuit of learning and embracing new opportunities at Roche. Roche is not just a place to work; it's a place where you can actively contribute to improving health outcomes of all patients worldwide. 🌟Let’s build a healthier future, together. Find out more about life at Roche. Learn more: https://lnkd.in/efW_pqhH
-
When you invest in health, you invest in everything. That’s what it’s worth. Across Europe, citizens are open to new approaches to improve healthcare. They also recognise the personal trade-offs that may be necessary to get there. According to 2025 research commissioned by Roche and conducted by GWI, access to quality care has become one of the public’s top priorities. Many Europeans are willing to embrace digital tools and data sharing to make care more efficient. People are clearly ready for change. But how do we get there? We believe investment in innovation is a crucial part of the answer. Investment in innovation is an investment in healthier populations, more effective health systems, more productive societies. 📄 Discover the full research here 👉 https://spkl.io/6047AemtD #HealthInEurope #WhatsItworth #HealthForAll #Policy #Innovation
-
Roche hat dies direkt geteilt
CEO Roche Group | Passionate about science, and committed to positively impacting people’s lives through healthcare
For billions of years, bacteria have evolved to survive - adapting faster than we can find ways to stop them. This is why antimicrobial resistance (AMR) is one of the biggest health challenges of our time. AMR is already making routine infections harder, and sometimes impossible, to treat. It affects everything from surgery and cancer care to neonatal medicine. At Roche, we are determined to play our part. Our long history in anti-infectives - from early antibiotics to life-saving antivirals - reminds us that scientific progress can change the course of global health. Today, our combined expertise in Diagnostics and Pharmaceuticals allows us to detect resistant infections earlier, guide targeted treatment decisions and advance innovative solutions that really matter for patients. Thank you to everyone contributing to this critical work! #Innovation #FutureOfHealthcare #WeAreRoche
-
For many, like diabetes advocate Michelle Schmidt (Diability GmbH), it’s about building the right support system and finding strength in connection. In our conversation with Michelle, she reminded us of the importance of reaching out, finding other people who face similar challenges, building a support network, and not hesitating to ask for help. Michelle’s story also highlights the power of small gestures. Her resilience and openness are a reminder to support one another in meaningful ways, no matter how big or small. Let’s amplify stories like Michelle’s, challenge stigma, cultivate empathy, and be part of the support system everyone deserves. Follow her for daily diabetes tips and see how she’s helping others with diabetes live their best lives. What’s one way you’ve shown or received support that made a difference? #DiabetesCare #DiabetesManagement #DiabetesLife
-
Roche hat dies direkt geteilt
CEO Roche Group | Passionate about science, and committed to positively impacting people’s lives through healthcare
If we think about who we are, much of it comes from our experiences, relationships and memories. Alzheimer’s disease takes these long before it affects the body. Today, Alzheimer’s is the seventh leading cause of death globally. More than 55 million people live with dementia, and up to 70% of these cases are Alzheimer’s. We also know that the disease can begin decades before symptoms appear – a crucial window which allows for earlier diagnosis and intervention. This is where Roche’s combined strength in Pharmaceuticals and Diagnostics makes a real difference. I recently spoke with Azad Bonni and Palani Kumaresan, Ph.D. about why progress has been so difficult and how new scientific advances are opening the door to earlier, simpler testing and to better treatment options: https://spkl.io/6048AdqEa #FutureOfHealthcare #PatientJourney #WeAreRoche #Healthtech #Healthcare
-
48% of people with diabetes feel their condition affects their ability to feel accepted in social and professional circles. But how can we foster more inclusive environments for those living with diabetes? For over 20 years, Sarah-Maria Richter has navigated life with type 1 diabetes—a journey that has profoundly shaped her experiences and perspective. With confidence, connection, and the support of her community, Sarah has learned how the inclusion of loved ones can create a diabetes-friendly environment. Her story is a powerful reminder that even small acts of support can make a big difference—whether among friends, within families, or in the workplace. Watch now and discover how we can work together to build a more compassionate and understanding world for those living with diabetes. #DiabetesCare #DiabetesManagement #DiabetesLife #Innovation Source: The data is based on bespoke data from a GWI research study commissioned by Roche, exploring diabetes and public perceptions of the condition. The study surveyed 16,310 internet users aged 18+ globally, including 4,326 people with diabetes, 912 with Type 1 diabetes, 3,312 with Type 2 diabetes and 11,984 who don’t have diabetes. The study was conducted in September 2025. Markets include Australia, Austria, Belgium, Brazil, Chile, Croatia, Czech Republic, Denmark, Germany, Hong Kong, India, Japan, Kuwait, Netherlands, Poland, Portugal, Romania, Saudi Arabia, South Africa, Spain, Turkey, and the UK.
-
💡 Knowledge check: When was the Golden Age of Antibiotics? Cast your vote in the poll 🗳️👇 Explore the story behind the answer, plus how we’re advancing antibiotic R&D at Roche: 🔗 https://spkl.io/6045AdWtZ #AMR #AntimicrobialResistance #AMRWeek #WAAW #RocheAMR
Dieser Inhalt ist hier nicht verfügbar.
Mit der LinkedIn App können Sie auf diese und weitere Inhalte zugreifen.
-
We find community in unexpected places, and for Ruotong Liu, an internship at Roche became a place of genuine connection, where collaboration and problem-solving are at the core of the culture. Our leaders empower you to achieve your fullest potential, fostering a culture where everyone can demonstrate leadership and navigate change with confidence. 🌟Let’s build a healthier future, together. Find out more about life at Roche. Learn more: https://lnkd.in/efW_pqhH
Verbundene Seiten
Ähnliche Seiten
Finanzierung
Letzte Runde
Kapitalerhöhung nach Börsengang5.000.000.000,00 $
Investor:innen